CD56-positive diffuse large B-cell lymphoma: comprehensive analysis of clinical, pathological, and molecular characteristics with literature review

Autor: Gasljevic Gorana, Boltezar Lucka, Novakovic Srdjan, Setrajcic-Dragos Vita, Jezersek-Novakovic Barbara, Kloboves-Prevodnik Veronika

Publikováno v: Radiology and Oncology, Vol 57, Iss 2, Pp 249-256 (2023)

Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma. The expression of CD56 in DLBCL is highly unusual. Little is known about its incidence and clinical importance. So far, no genetic profiling was performed in CD56 positive

Externí odkaz: https://doaj.org/article/30ea96c1ef474f81a6a71ae87081a1de

Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors

Autor: Lampelj Maja, Arko Darja, Cas-Sikosek Nina, Kavalar Rajko, Ravnik Maja, Jezersek-Novakovic Barbara, Dobnik Sarah, Dovnik Nina Fokter, Takac Iztok

Publikováno v: Radiology and Oncology, Vol 49, Iss 4, Pp 357-364 (2015)

Background. Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) play a key role in tumour invasion and metastasis. High levels of both proteolytic enzymes are associated with poor prognosis in breast cancer patien

Externí odkaz: https://doaj.org/article/0a111196451a4433865db452f0c6d85d

Treatment outcomes and survival in patients with primary central nervous system lymphomas treated between 1995 and 2010 - a single centre report.

Autor: Jezersek Novakovic, Barbara

Publikováno v: Radiology & Oncology; 2012, Vol. 46 Issue 4, p346-353, 8p, 2 Charts, 5 Graphs

Diagnostic value of immunoglobulin κ light chain gene rearrangement analysis in B-cell lymphomas.

Autor: Kokovic I; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Jezersek Novakovic B; Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Novakovic S; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia.

Publikováno v: International journal of oncology [Int J Oncol] 2015 Mar; Vol. 46 (3), pp. 953-62. Date of Electronic Publication: 2014 Dec 09.

Tumor vaccine composed of CpG ODN class C and irradiated tumor cells up-regulates the expression of genes characteristic of mature dendritic cells and of memory cells.

Autor: Cerkovnik P; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia., Jezersek Novakovic B, Stegel V, Novakovic S

Publikováno v: International journal of oncology [Int J Oncol] 2011 Jun; Vol. 38 (6), pp. 1749-58. Date of Electronic Publication: 2011 Mar 17.